Lumexa Imaging Holdings Outlines 2026 Free Cash Flow Targets and Market Expansion Strategy
Lumexa Imaging Holdings (LMRI) reported progress in its strategic mission to establish a premier platform for high-quality, low-cost outpatient imaging. During the Q3 2026 earnings call, CEO Caitlin Zulla highlighted significant operational momentum, noting that the company achieved an 11% growth in EBITDA during the quarter. Looking ahead, Lumexa has set ambitious financial targets, aiming for at least a 30% free cash flow conversion rate by 2026. The company is positioning itself to capture a share of a projected $77 billion total addressable market within the outpatient imaging sector.
Topics: earnings EBITDA outpatient imaging
Read the full article at Seeking Alpha
Part of the story Uber Reports Strong Free Cash Flow and Outlines Autonomous Vehicle Strategy (4 articles)